Ortin Laboratories Valuation
| ORTINLAB | 19.63 0.00 0.00% |
At this time, the company appears to be overvalued. Ortin Laboratories holds a recent Real Value of USD17.02 per share. The prevailing price of the company is USD19.63. Our model determines the value of Ortin Laboratories from analyzing the company fundamentals such as Current Valuation of 155.99 M, price to book of 5.65 X, and Return On Equity of -1.17 as well as examining its technical indicators and probability of bankruptcy.
Price Book 5.6524 | Enterprise Value 156 M | Enterprise Value Ebitda (6.42) | Price Sales 22.1084 | Enterprise Value Revenue 8.338 |
Overvalued
Today
Please note that Ortin Laboratories' price fluctuation is very steady at this time. Calculation of the real value of Ortin Laboratories is based on 3 months time horizon. Increasing Ortin Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ortin Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ortin Stock. However, Ortin Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.63 | Real 17.02 | Hype 19.63 |
The real value of Ortin Stock, also known as its intrinsic value, is the underlying worth of Ortin Laboratories Company, which is reflected in its stock price. It is based on Ortin Laboratories' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ortin Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ortin Laboratories Limited helps investors to forecast how Ortin stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ortin Laboratories more accurately as focusing exclusively on Ortin Laboratories' fundamentals will not take into account other important factors: Ortin Laboratories Cash |
|
Ortin Laboratories Total Value Analysis
Ortin Laboratories Limited is now expected to have takeover price of 155.99 M with market capitalization of 165.64 M, debt of 18.02 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ortin Laboratories fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
155.99 M | 165.64 M | 18.02 M |
Ortin Laboratories Investor Information
About 27.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 10.04. Ortin Laboratories had not issued any dividends in recent years. The entity had 48:100 split on the 12th of January 2021. Based on the key indicators related to Ortin Laboratories' liquidity, profitability, solvency, and operating efficiency, Ortin Laboratories Limited is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Ortin Laboratories Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ortin Laboratories has an asset utilization ratio of 31.68 percent. This suggests that the Company is making USD0.32 for each dollar of assets. An increasing asset utilization means that Ortin Laboratories Limited is more efficient with each dollar of assets it utilizes for everyday operations.Ortin Laboratories Ownership Allocation
The market capitalization of Ortin Laboratories is USD165.64 Million. Ortin Laboratories has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Ortin Laboratories Profitability Analysis
The company reported the revenue of 21.11 M. Net Loss for the year was (80.41 M) with profit before overhead, payroll, taxes, and interest of 25.39 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ortin Laboratories' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ortin Laboratories and how it compares across the competition.
About Ortin Laboratories Valuation
The stock valuation mechanism determines Ortin Laboratories' current worth on a weekly basis. Our valuation model uses a comparative analysis of Ortin Laboratories. We calculate exposure to Ortin Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ortin Laboratories's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -23.9 M | -22.7 M |
Ortin Laboratories Quarterly Retained Earnings |
|
Complementary Tools for Ortin Stock analysis
When running Ortin Laboratories' price analysis, check to measure Ortin Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ortin Laboratories is operating at the current time. Most of Ortin Laboratories' value examination focuses on studying past and present price action to predict the probability of Ortin Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ortin Laboratories' price. Additionally, you may evaluate how the addition of Ortin Laboratories to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |